Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 65, Issue 15, Pages 10195-10216Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.2c00755
Keywords
-
Categories
Ask authors/readers for more resources
Globalization, global warming, and population aging have contributed to the spread of emerging viruses. The COVID-19 pandemic has highlighted the need for new broad-spectrum antiviral agents. DDX3X helicase has been identified as a host factor required for viral replication and can be targeted as a broad-spectrum antiviral drug.
In recent years, globalization, global warming, and population aging have contributed to the spread of emerging viruses, such as coronaviruses (COVs), West Nile (WNV), Dengue (DENV), and Zika (ZIKV). The number of reported infections is increasing, and considering the high viral mutation rate, it is conceivable that it will increase significantly in the coming years. The risk caused by viruses is now more evident due to the COVID-19 pandemic, which highlighted the need to find new broad-spectrum antiviral agents able to tackle the present pandemic and future epidemics. DDX3X helicase is a host factor required for viral replication. Selective inhibitors have been identified and developed into broad-spectrum antivirals active against emerging pathogens, including SARS-CoV-2 and most importantly against drug-resistant strains. This perspective describes the inhibitors identified in the last years, highlighting their therapeutic potential as innovative broad-spectrum antivirals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available